Indian Kanoon - Search engine for Indian Law

office at Bangalore, Kamataka - 561229, is a co-developer of a purported biosimilar version of Trastuzumab, along with defendant No.3, Mylan Inc., a corporation ... Limited. Defendant No.2 after filing of the suit markets its purported biosimilar Trastuzumab in India under the brand name CANMAb. 4. Defendant

that the defendant's drug has not been tested as a biosimilar product under applicable law, defendant No.3's CTR Registration Number ... defendant No.3's drug, TrastuRel ("TrastuRel"), a purported biosimilar version of the plaintiffs' biological drug Trastuzumab (the "plaintiffs